France · Delayed Price · Currency is EUR Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 97.02 billion. The enterprise value is 111.26 billion.
| Market Cap | 97.02B |
| Enterprise Value | 111.26B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | May 5, 2026 |
Share Statistics
Sanofi has 1.20 billion shares outstanding. The number of shares has decreased by -2.18% in one year.
| Current Share Class | 1.20B |
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 43.20% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 23.42 and the forward PE ratio is 8.81. Sanofi's PEG ratio is 1.05.
| PE Ratio | 23.42 |
| Forward PE | 8.81 |
| PS Ratio | 1.90 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 18.47 |
| P/FCF Ratio | 9.73 |
| P/OCF Ratio | 8.11 |
| PEG Ratio | 1.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.66, with an EV/FCF ratio of 11.16.
| EV / Earnings | 26.63 |
| EV / Sales | 2.18 |
| EV / EBITDA | 7.66 |
| EV / EBIT | 10.27 |
| EV / FCF | 11.16 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.12 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | 1.99 |
| Interest Coverage | 17.51 |
Financial Efficiency
Return on equity (ROE) is 5.71% and return on invested capital (ROIC) is 9.02%.
| Return on Equity (ROE) | 5.71% |
| Return on Assets (ROA) | 5.31% |
| Return on Invested Capital (ROIC) | 9.02% |
| Return on Capital Employed (ROCE) | 10.99% |
| Weighted Average Cost of Capital (WACC) | 5.08% |
| Revenue Per Employee | 681,159 |
| Profits Per Employee | 55,821 |
| Employee Count | 74,846 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.54 |
Taxes
In the past 12 months, Sanofi has paid 1.72 billion in taxes.
| Income Tax | 1.72B |
| Effective Tax Rate | 29.05% |
Stock Price Statistics
The stock price has decreased by -7.56% in the last 52 weeks. The beta is 0.26, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -7.56% |
| 50-Day Moving Average | 74.20 |
| 200-Day Moving Average | 76.64 |
| Relative Strength Index (RSI) | 75.47 |
| Average Volume (20 Days) | 2,511,978 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 50.98 billion and earned 4.18 billion in profits. Earnings per share was 3.46.
| Revenue | 50.98B |
| Gross Profit | 37.57B |
| Operating Income | 11.05B |
| Pretax Income | 5.91B |
| Net Income | 4.18B |
| EBITDA | 14.47B |
| EBIT | 11.05B |
| Earnings Per Share (EPS) | 3.46 |
Balance Sheet
The company has 5.97 billion in cash and 19.85 billion in debt, with a net cash position of -13.88 billion or -11.58 per share.
| Cash & Cash Equivalents | 5.97B |
| Total Debt | 19.85B |
| Net Cash | -13.88B |
| Net Cash Per Share | -11.58 |
| Equity (Book Value) | 73.24B |
| Book Value Per Share | 60.73 |
| Working Capital | 3.44B |
Cash Flow
In the last 12 months, operating cash flow was 11.96 billion and capital expenditures -1.99 billion, giving a free cash flow of 9.97 billion.
| Operating Cash Flow | 11.96B |
| Capital Expenditures | -1.99B |
| Depreciation & Amortization | 3.42B |
| Net Borrowing | 1.50B |
| Free Cash Flow | 9.97B |
| FCF Per Share | 8.32 |
Margins
Gross margin is 73.68%, with operating and profit margins of 21.67% and 8.20%.
| Gross Margin | 73.68% |
| Operating Margin | 21.67% |
| Pretax Margin | 11.59% |
| Profit Margin | 8.20% |
| EBITDA Margin | 28.37% |
| EBIT Margin | 21.67% |
| FCF Margin | 19.56% |
Dividends & Yields
This stock pays an annual dividend of 4.12, which amounts to a dividend yield of 5.09%.
| Dividend Per Share | 4.12 |
| Dividend Yield | 5.09% |
| Dividend Growth (YoY) | 5.10% |
| Years of Dividend Growth | 25 |
| Payout Ratio | 232.05% |
| FCF Payout Ratio | 49.17% |
| Buyback Yield | 2.18% |
| Shareholder Yield | 7.27% |
| Earnings Yield | 4.27% |
| FCF Yield | 10.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sanofi is 94.10, which is 16.20% higher than the current price. The consensus rating is "Buy".
| Price Target | 94.10 |
| Price Target Difference | 16.20% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 4.91% |
| EPS Growth Forecast (3Y) | 8.98% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |